HomePTGX • NASDAQ
add
Protagonist Therapeutics Inc
Previous close
$53.82
Day range
$53.10 - $54.97
Year range
$30.67 - $60.57
Market cap
3.37B USD
Avg Volume
836.94K
P/E ratio
71.68
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 28.32M | -88.89% |
Operating expense | 47.63M | -2.08% |
Net income | -11.66M | -105.62% |
Net profit margin | -41.15 | -150.60% |
Earnings per share | -0.19 | -105.83% |
EBITDA | -19.07M | -109.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 574.36M | 78.02% |
Total assets | 742.13M | 17.93% |
Total liabilities | 53.08M | -22.88% |
Total equity | 689.05M | — |
Shares outstanding | 61.98M | — |
Price to book | 4.84 | — |
Return on assets | -6.49% | — |
Return on capital | -6.96% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -11.66M | -105.62% |
Cash from operations | 125.36M | 557.05% |
Cash from investing | -94.40M | -1,654.97% |
Cash from financing | 11.44M | 58.95% |
Net change in cash | 42.40M | 399.48% |
Free cash flow | 129.88M | 197.82% |
About
Founded
2006
Headquarters
Website
Employees
124